APA

Koizumi A., Shoji Y., Nozaki J., Noguchi A., E X., Dakeishi M., Ohura T., Tsuyoshi K., Yasuhiko W., Manabe M., Takasago Y. & Takada G. (20001030). A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. The Mass Screening Group. : Human mutation.

Chicago

Koizumi A, Shoji Y, Nozaki J, Noguchi A, E X, Dakeishi M, Ohura T, Tsuyoshi K, Yasuhiko W, Manabe M, Takasago Y and Takada G. 20001030. A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. The Mass Screening Group. : Human mutation.

Harvard

Koizumi A., Shoji Y., Nozaki J., Noguchi A., E X., Dakeishi M., Ohura T., Tsuyoshi K., Yasuhiko W., Manabe M., Takasago Y. and Takada G. (20001030). A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. The Mass Screening Group. : Human mutation.

MLA

Koizumi A, Shoji Y, Nozaki J, Noguchi A, E X, Dakeishi M, Ohura T, Tsuyoshi K, Yasuhiko W, Manabe M, Takasago Y and Takada G. A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. The Mass Screening Group. : Human mutation. 20001030.